# US 8,278,451 B2 · Pseudoazulenyl nitrones

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,451 B2
- Document ID: US8278451B2
- Status: Granted
- Kind: B2
- Application number: 12/306,246
- Filed: 2007-06-27
- Published: 2010-01-21
- Granted: 2012-10-02
- Earliest claimed: 2006-06-28
- Assignees: The Florida International University Board of Trustees
- Inventors: David A. Becker; Amolkumar Kolhe
- Web page: https://patentgrep.com/patent/US8278451B2

## CPC

- C07D 221/04: Ortho- or peri-condensed ring systems
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C07D 311/94: condensed with rings other than six-membered or with ring systems containing such rings
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein are pseudoazulenyl nitrone compounds and methods of using these compounds to trap free radicals and to treat, prevent, or ameliorate various diseases associated with free radicals.

## Claims

### Claim 1

A compound having a general structural formula (I) or formula (II):
wherein R1, R5, and R7 are the same or different and are independently selected from the group consisting of hydrogen, C1-4 alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, tris(3-hydroxypropyl)methyl, (3-carboxy-1,1-dimethyl)propyl, and 3-sulfonatophenyl; R2, R6, and R9 are the same or different and are selected from the group consisting of hydrogen, C═C(H)N+(R1)O−, C1-22alkyl, C1-10alkyleneOC(O)C1-10alkyl, and CHO; R3 is selected from the group consisting of hydrogen, C1-22alkyl, SR12, and SO3−; X is selected from the group consisting of O, S, and NR4; X′ is selected from the group consisting of O, S, and NR8; R4 and R8 are the same or different and are selected from the group consisting of hydrogen, C1-22 alkyl, phenyl, substituted phenyl, (C1-22alkyleneN(R12)2+)nC1-22alkyleneN(R12)2, C1-22alkyleneOR11, C1-22alkyleneP(R1)3+, C1-22alkylene aryl, C1-22alkylene substituted aryl, C1-22alkylene heteroaryl, and C1-22alkylene substituted heteroaryl; R10 is independently selected from the group consisting of hydrogen, C1-10alkyl, C1-10alkyleneN(R12)3+, and C1-10alkylene-C6H4—C1-10alkyleneN(R12)3+; R11 is selected from the group consisting of hydrogen, C1-10alkyl, SO2CF3, SO2CH3, SO2C6H4CH3, and SO2C4F9; and R12 is selected from the group consisting of hydrogen, C1-22alkyl, aryl, heteroaryl, substituted aryl, and substituted heteroaryl; n is an integer from 0 to 3; or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The compound of claim 1, wherein X is NR4; X′ is NR8, or X is NR4 and X′ is NR8.

### Claim 3 (depends on 1)

The compound of claim 1, wherein R2 is C═C(H)N+(R1)O−.

### Claim 4 (depends on 1)

The compound of claim 1, wherein X is O or X′ is O, or X and X′ are each O.

### Claim 5 (depends on 1)

The compound of claim 1 selected from the group consisting of:

### Claim 6 (depends on 1)

The compound of claim 1 selected from the group consisting
wherein Ph is phenyl and tBu is tert-butyl.

### Claim 7 (depends on 1)

A method of trapping a reactive free radical comprising contacting a compound of claim 1 with the reactive free radical to form an adduct of the compound and the reactive free radical.

### Claim 8 (depends on 1)

A method of screening for free radicals comprising contacting a compound suspected of producing free radicals with a compound of claim 1 to form an adduct of the free radical and the compound of claim 1, and measuring a ratio of the adduct to the compound of claim 1, wherein a ratio greater than 0 indicates the presence of free radicals.
